Secretion of a Chimeric T-cell Receptor-immunoglobulin Protein
Overview
Affiliations
To produce sufficient quantities of soluble T-cell receptor protein for detailed biochemical and biophysical analyses we have explored the use of immunoglobulin--T-cell receptor gene fusions. In this report we describe a chimeric gene construct containing a T-cell receptor alpha-chain variable (V) domain and the constant (C) region coding sequences of an immunoglobulin gamma 2a molecule. Cells transfected with the chimeric gene synthesize a stable protein product that expresses immunoglobulin and T-cell receptor antigenic determinants as well as protein A binding sites. We show that the determinant recognized by the anticlonotypic antibody A2B4.2 resides on the V alpha domain of the T-cell receptor. The chimeric protein associates with a normal lambda light chain to form an apparently normal tetrameric (H2L2, where H = heavy and L = light) immunoglobulin molecule that is secreted. Also of potential significance is the fact that a T-cell receptor V beta gene in the same construct is neither assembled nor secreted with the lambda light chain, and when expressed with a C kappa region it does not assemble with the chimeric V alpha C gamma 2a protein mentioned above. This indicates that not all T-cell receptor V regions are similar enough to immunoglobulin V regions for them to be completely interchangeable.
Signaling from T cell receptors (TCRs) and chimeric antigen receptors (CARs) on T cells.
Wu L, Wei Q, Brzostek J, Gascoigne N Cell Mol Immunol. 2020; 17(6):600-612.
PMID: 32451454 PMC: 7264185. DOI: 10.1038/s41423-020-0470-3.
Huang C, Chang C, Chen C, Ho S, Chang H, Chu Y Genes (Basel). 2018; 9(2).
PMID: 29443925 PMC: 5852587. DOI: 10.3390/genes9020091.
Stabilizing mutations increase secretion of functional soluble TCR-Ig fusion proteins.
Lunde E, Loset G, Bogen B, Sandlie I BMC Biotechnol. 2010; 10:61.
PMID: 20735812 PMC: 2936418. DOI: 10.1186/1472-6750-10-61.
Mizue Terai , Tamura Y, Alexeev V, Ohtsuka E, Berd D, Mastrangelo M Cancer Immunol Immunother. 2009; 58(8):1307-17.
PMID: 19142637 PMC: 11030067. DOI: 10.1007/s00262-008-0644-9.
Woll M, Fisher C, Ryan G, Gurney J, Storrer C, Ioannides C J Clin Immunol. 2004; 24(4):449-61.
PMID: 15163902 DOI: 10.1023/B:JOCI.0000029117.10791.98.